Skip to main content
Premium Trial:

Request an Annual Quote

IP Watch: Epigenomics, New England Biolabs, Life Tech, Others Win US Patents


The University of Houston has been awarded US Patent No. 8,753,496, "Method for monitored separation and collection of biological materials."

George Jackson, Richard Willson, and George Fox are named as inventors.

Epigenomics has been awarded US Patent No. 8,753,810, "Method for the carry-over protection in DNA amplification systems targeting methylation analysis achieved by a modified pre-treatment of nucleic acids."

Reimo Tetzner and Dimo Dietrich are named as inventors.

Stanford has been awarded US Patent No. 8,753,812, "Charge perturbation detection method for DNA and other molecules."

Nader Pourmand, Miloslav Karhanek, and Ronald Davis are named as inventors.

Rutgers has been awarded US Patent No. 8,753,819, "Assays for resistance to echinocandin-class drugs."

David Perlin, Steven Park, Cameron Douglas, Jennifer Kahn, Stephen Parent, and Rosemarie Kelly are named as inventors.

Life Technologies (Thermo Fisher Scientific) has been awarded US Patent No. 8,753,845, "Thermostable reverse transcriptases and uses thereof."

Gulshan Dhariwal, Gary Gerard, Jun Lee, Robert Potter, Kim Rosenthal, and Michael Smith are named as inventors.

New England Biolabs has been awarded US Patent No. 8,753,847, "Selection and enrichment of proteins using in vitro compartmentalization."

Yu Zheng and Richard Roberts are named as inventors.

The Invention Science Fund I has been awarded US Patent No. 8,754,055, "Methods, compositions, and kits for collecting and detecting oligonucleotides."

Paul Allen, Edward Boyden, Roderick Hyde, Muriel Ishikawa, Stephen Malaska, Dennis Rivet, Leif Stordal, and Lowell Wood, Jr. are named as inventors.

Olympus has been awarded US Patent No. 8,754,204, "Method for preparing stool sample, solution for preparing stool sample, and kit for collecting stool."

Yasuo Tanigami and Tomonori Nagaoka are named as inventors.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.